97 related articles for article (PubMed ID: 19069446)
1. [Possibilities of estimating the density of lymphocytic surface receptors from the mean fluorescence strength by flow cytofluorometry. Standardization of analytical conditions].
Naumova EV; Pochtar' ME; Luzin MN
Klin Lab Diagn; 2008 Oct; (10):43-8. PubMed ID: 19069446
[No Abstract] [Full Text] [Related]
2. Quantitative flow cytometry of ZAP-70 levels in chronic lymphocytic leukemia using molecules of equivalent soluble fluorochrome.
Kay S; Herishanu Y; Pick M; Rogowski O; Baron S; Naparstek E; Polliack A; Deutsch VR
Cytometry B Clin Cytom; 2006 Jul; 70(4):218-26. PubMed ID: 16456869
[TBL] [Abstract][Full Text] [Related]
3. Analyzing B cell chronic lymphocytic leukemia with Oncomark tubes on a FACSCanto.
Warzynski MJ; Rawlings PL
Cytometry B Clin Cytom; 2007 Sep; 72(5):418-22. PubMed ID: 17226864
[No Abstract] [Full Text] [Related]
4. Residual cancer lymphocytes in patients with chronic lymphocytic leukemia after therapy show increased expression of surface antigen CD52 detected using quantitative fluorescence cytometry.
Pevna M; Doubek M; Coupek P; Stehlikova O; Klabusay M
Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):411-8. PubMed ID: 25066039
[TBL] [Abstract][Full Text] [Related]
5. Standardization and quantitation in flow cytometry.
Hoffman RA
Methods Cell Biol; 2001; 63():299-340. PubMed ID: 11060847
[No Abstract] [Full Text] [Related]
6. Standardization, calibration, and control in flow cytometry.
Hoffman RA
Curr Protoc Cytom; 2005 May; Chapter 1():Unit 1.3. PubMed ID: 18770811
[TBL] [Abstract][Full Text] [Related]
7. No effect of lysis solutions on absolute CD19+ lymphocytes count and CD45 index in chronic lymphocytic leukemia.
Mekouar H; Mullier F; Dinon Q; Bailly N; Cornet Y; Chatelain B
Cytometry B Clin Cytom; 2011 Nov; 80(6):369-72. PubMed ID: 21638772
[TBL] [Abstract][Full Text] [Related]
8. Holding on to the Matutes score while dropping FMC7: new opportunity from standardised approaches in multiparameter flow cytometry.
Zhu J; Raimbault A; Sourdeau E; Maillon A; Mathis S; Capron C; Lemaire P; Ronez E; Moatti H; Jondeau K; Clauser S; Bardet V
Br J Haematol; 2020 Aug; 190(4):e255-e258. PubMed ID: 32557566
[No Abstract] [Full Text] [Related]
9. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric analysis of CD5+ B cells: a frame of reference for minimal residual disease analysis in chronic lymphocytic leukemia.
Gupta R; Jain P; Deo SV; Sharma A
Am J Clin Pathol; 2004 Mar; 121(3):368-72. PubMed ID: 15023041
[TBL] [Abstract][Full Text] [Related]
11. Calibration standards for antigen quantification in CLL.
Kay N
Cytometry B Clin Cytom; 2008 Mar; 74(2):137; author reply 138. PubMed ID: 17849486
[No Abstract] [Full Text] [Related]
12. Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma.
Ise T; Nagata S; Kreitman RJ; Wilson WH; Wayne AS; Stetler-Stevenson M; Bishop MR; Scheinberg DA; Rassenti L; Kipps TJ; Kyle RA; Jelinek DF; Pastan I
Leukemia; 2007 Jan; 21(1):169-74. PubMed ID: 17051241
[TBL] [Abstract][Full Text] [Related]
13. Optimization of flow cytometric measurement of ZAP-70 in chronic lymphocytic leukemia.
Preobrazhensky SN; Bahler DW
Cytometry B Clin Cytom; 2008 Mar; 74(2):118-27. PubMed ID: 17948236
[TBL] [Abstract][Full Text] [Related]
14. Combination of cellular population data and CytoDiff analyses for the diagnosis of lymphocytosis.
Jean A; Boutet C; Lenormand B; Callat MP; Buchonnet G; Leclerc C; Vasse M
Clin Chem Lab Med; 2011 Nov; 49(11):1861-8. PubMed ID: 21875393
[TBL] [Abstract][Full Text] [Related]
15. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal B lymphocytosis versus chronic lymphocytic leukemia: factors affecting implementation of an absolute threshold.
Rollins-Raval MA; Fisher J; Craig FE
Cytometry B Clin Cytom; 2013 May; 84(3):149-56. PubMed ID: 23475845
[TBL] [Abstract][Full Text] [Related]
17. Measurement of lymphocyte aggregation by flow cytometry-physiological implications in chronic lymphocytic leukemia.
Dezorella N; Kay S; Baron S; Shapiro M; Porat Z; Deutsch V; Herishanu Y; Katz BZ
Cytometry B Clin Cytom; 2016 May; 90(3):257-66. PubMed ID: 26082241
[TBL] [Abstract][Full Text] [Related]
18. Performance of calibration standards for antigen quantitation with flow cytometry in chronic lymphocytic leukemia.
Rossmann ED; Lenkei R; Lundin J; Mellstedt H; Osterborg A
Cytometry B Clin Cytom; 2007 Nov; 72(6):450-7. PubMed ID: 17565749
[TBL] [Abstract][Full Text] [Related]
19. Blood microvesicles during chronic lymphoproliferative diseases.
Domnikova NP; Dolgikh TY; Sholenberg EV; Vorontsova EV; Goreva OB; Mel'nikova EV; Gorbachenko EA; Grishanova AY
Bull Exp Biol Med; 2013 Nov; 156(1):94-7. PubMed ID: 24319739
[TBL] [Abstract][Full Text] [Related]
20. ZAP-70 in CLL: towards standardization of a biomarker for patient management: history of clinical cytometry special issue.
Marti G; Orfao A; Goolsby C
Cytometry B Clin Cytom; 2006 Jul; 70(4):197-200. PubMed ID: 16906575
[No Abstract] [Full Text] [Related]
[Next] [New Search]
